BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33562358)

  • 1. The GAUGAA Motif Is Responsible for the Binding between circSMARCA5 and SRSF1 and Related Downstream Effects on Glioblastoma Multiforme Cell Migration and Angiogenic Potential.
    Barbagallo D; Caponnetto A; Barbagallo C; Battaglia R; Mirabella F; Brex D; Stella M; Broggi G; Altieri R; Certo F; Caltabiano R; Barbagallo GMV; Anfuso CD; Lupo G; Ragusa M; Di Pietro C; Hansen TB; Purrello M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
    Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircSMARCA5 Regulates VEGFA mRNA Splicing and Angiogenesis in Glioblastoma Multiforme Through the Binding of SRSF1.
    Barbagallo D; Caponnetto A; Brex D; Mirabella F; Barbagallo C; Lauretta G; Morrone A; Certo F; Broggi G; Caltabiano R; Barbagallo GM; Spina-Purrello V; Ragusa M; Di Pietro C; Hansen TB; Purrello M
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30736462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRSF10 inhibits biogenesis of circ-ATXN1 to regulate glioma angiogenesis via miR-526b-3p/MMP2 pathway.
    Liu X; Shen S; Zhu L; Su R; Zheng J; Ruan X; Shao L; Wang D; Yang C; Liu Y
    J Exp Clin Cancer Res; 2020 Jun; 39(1):121. PubMed ID: 32600379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer.
    Cai J; Chen Z; Zuo X
    Dis Markers; 2019; 2019():2473652. PubMed ID: 30956729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. circSMARCA5 Is an Upstream Regulator of the Expression of miR-126-3p, miR-515-5p, and Their mRNA Targets,
    Merulla AE; Stella M; Barbagallo C; Battaglia R; Caponnetto A; Broggi G; Altieri R; Certo F; Caltabiano R; Ragusa M; Barbagallo GMV; Di Pietro C; Purrello M; Barbagallo D
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using circular RNA SMARCA5 as a potential novel biomarker for hepatocellular carcinoma.
    Li Z; Zhou Y; Yang G; He S; Qiu X; Zhang L; Deng Q; Zheng F
    Clin Chim Acta; 2019 May; 492():37-44. PubMed ID: 30716279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of circular RNA SMARCA5/microRNA-620 axis in the regulation of cervical cancer cell proliferation, invasion and migration.
    Tian JDC; Liang L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8589-8598. PubMed ID: 30575898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircRNA inhibits DNA damage repair by interacting with host gene.
    Xu X; Zhang J; Tian Y; Gao Y; Dong X; Chen W; Yuan X; Yin W; Xu J; Chen K; He C; Wei L
    Mol Cancer; 2020 Aug; 19(1):128. PubMed ID: 32838810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of hsa_circ_0001445 reverses oxLDL‑induced inhibition of HUVEC proliferation via SRSF1.
    Liang G; Chen S; Xin S; Dong L
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of cytoskeleton protein ADD3 promotes tumor growth and angiogenesis in glioblastoma multiforme.
    Kiang KM; Zhang P; Li N; Zhu Z; Jin L; Leung GK
    Cancer Lett; 2020 Apr; 474():118-126. PubMed ID: 31958485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1.
    Wagner KD; El Maï M; Ladomery M; Belali T; Leccia N; Michiels JF; Wagner N
    Cells; 2019 Jan; 8(1):. PubMed ID: 30641926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
    Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
    Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA MIR205HG regulates KRT17 and tumor processes in cervical cancer via interaction with SRSF1.
    Dong M; Dong Z; Zhu X; Zhang Y; Song L
    Exp Mol Pathol; 2019 Dec; 111():104322. PubMed ID: 31655037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA SMARCA5 functions as an anti-tumor candidate in colon cancer by sponging microRNA-552.
    Yang S; Gao S; Liu T; Liu J; Zheng X; Li Z
    Cell Cycle; 2021 Apr; 20(7):689-701. PubMed ID: 33749508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer.
    Wang J; Liu T; Wang M; Lv W; Wang Y; Jia Y; Zhang R; Liu L
    J Cell Biochem; 2020 Feb; 121(2):946-953. PubMed ID: 31478261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aquaporin 1 elicits cell motility and coordinates vascular bed formation by downregulating thrombospondin type-1 domain-containing 7A in glioblastoma.
    Oishi M; Munesue S; Harashima A; Nakada M; Yamamoto Y; Hayashi Y
    Cancer Med; 2020 Jun; 9(11):3904-3917. PubMed ID: 32253832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpressed circ_0029426 in glioblastoma forecasts unfavorable prognosis and promotes cell progression by sponging miR-197.
    Zhang G; Sun W; Zhu L; Feng Y; Wu L; Li T
    J Cell Biochem; 2019 Jun; 120(6):10295-10302. PubMed ID: 30548670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRSF1-Regulated Alternative Splicing in Breast Cancer.
    Anczuków O; Akerman M; Cléry A; Wu J; Shen C; Shirole NH; Raimer A; Sun S; Jensen MA; Hua Y; Allain FH; Krainer AR
    Mol Cell; 2015 Oct; 60(1):105-17. PubMed ID: 26431027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells.
    Moreno MJ; Ball M; Andrade MF; McDermid A; Stanimirovic DB
    Glia; 2006 Jun; 53(8):845-57. PubMed ID: 16586492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.